Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)
OTCMKTS · Delayed Price · Currency is USD
1.170
+0.080 (7.34%)
At close: Jul 29, 2025
Genomma Lab Internacional Market Cap
Genomma Lab Internacional has a market cap or net worth of $1.19 billion as of September 9, 2025. Its market cap has increased by 25.05% in one year.
Market Cap
1.19B
Enterprise Value
1.44B
Revenue
999.08M
Ranking
n/a
PE Ratio
11.53
Stock Price
$1.17
Market Cap Chart
Since June 23, 2008, Genomma Lab Internacional's market cap has increased from 435.89M to 1.19B, an increase of 172.27%. That is a compound annual growth rate of 5.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 1.19B | 6.39% |
| Dec 31, 2024 | 1.12B | 43.29% |
| Dec 29, 2023 | 778.50M | -9.87% |
| Dec 30, 2022 | 863.79M | -18.07% |
| Dec 31, 2021 | 1.05B | 10.06% |
| Dec 31, 2020 | 957.93M | -4.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.85M |
| HealthLynked | 499.79M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |